A Double-Blind, Placebo-Controlled Study of a Flexible Dose of Venlafaxine ER in Adult Outpatients With Generalized Social Anxiety Disorder

@article{Rickels2004ADP,
  title={A Double-Blind, Placebo-Controlled Study of a Flexible Dose of Venlafaxine ER in Adult Outpatients With Generalized Social Anxiety Disorder},
  author={K. Rickels and R. Mangano and A. Khan},
  journal={Journal of Clinical Psychopharmacology},
  year={2004},
  volume={24},
  pages={488-496}
}
Abstract: Venlafaxine extended release (ER) is a dual serotonin-norepinephrine reuptake inhibitor previously shown to be effective in the treatment of major depressive disorder and generalized anxiety disorder. This placebo-controlled, multicenter, randomized, double-blind trial examined the efficacy and safety of venlafaxine ER in outpatients with generalized social anxiety disorder. Two hundred seventy-two outpatients were randomly assigned to receive either a flexible dose of venlafaxine ER… Expand
View on Wolters Kluwer
ncbi.nlm.nih.gov
87 Citations
Highly Influential Citations
6
Background Citations
13
Methods Citations
1
Results Citations
2

Paper Mentions

Interventional Clinical Trial
The Effect of Venlafaxine on Language Function in Patients With Subcortical Aphasia: A fMRI Study
Previous studies have demonstrated that venlafaxine significantly improves the language function of healthy subjects and increase of fMRI activation in cortical language area. This… Expand
ConditionsIschemic Stroke, Subcortical Aphasia
InterventionDrug
Guangzhou General Hospital of Guangzhou Military Command
August 2018 - August 2019

87 Citations

Citation Type

Citation Type

A double‐blind study of the efficacy of venlafaxine extended‐release, paroxetine, and placebo in the treatment of panic disorder
  • 87
A 12-Week Double-Blind, Placebo-Controlled, Flexible-Dose Trial of Desvenlafaxine Extended-Release Tablets in Generalized Social AnxietyDisorder
  • 1
A randomized controlled trial of venlafaxine ER and paroxetine in the treatment of outpatients with panic disorder
  • 23
A Randomized Controlled Trial of Venlafaxine ER Versus Placebo in Pediatric Social Anxiety Disorder
  • 119
A Multicenter, Placebo‐Controlled, Double‐Blind, Randomized Study of Efficacy and Safety of Ocinaplon (DOV 273,547) in Generalized Anxiety Disorder
  • 23
Long-term efficacy of pregabalin in generalized anxiety disorder
  • 108
Venlafaxine extended release versus conventional antidepressants in the remission of depressive disorders after previous antidepressant failure: ARGOS study
  • 68
Second-generation antidepressants in social anxiety disorder: meta-analysis of controlled clinical trials
  • 20
  • Highly Influenced
SNRIs: The Pharmacology, Clinical Efficacy, and Tolerability in Comparison with Other Classes of Antidepressants
  • 404
Mirtazapine Treatment of Social Phobia in Women: A Randomized, Double-Blind, Placebo-Controlled Study
  • 60
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 51 REFERENCES
A double-blind, randomized, placebo-controlled trial of once-daily venlafaxine extended release (XR) and fluoxetine for the treatment of depression.
  • 154
Once-daily venlafaxine extended release (XR) compared with fluoxetine in outpatients with depression and anxiety. Venlafaxine XR 360 Study Group.
  • 219
Efficacy and tolerability of once-daily venlafaxine extended release (XR) in outpatients with major depression. The Venlafaxine XR 209 Study Group.
  • M. Thase
  • Medicine
  • The Journal of clinical psychiatry
  • 1997
  • 31
The use of venlafaxine in the treatment of major depression and major depression associated with anxiety: a dose-response study. Venlafaxine Investigator Study Group.
  • 84
Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial.
  • 228
Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial.
  • 264
  • PDF
Efficacy of once-daily venlafaxine extended release (XR) for symptoms of anxiety in depressed outpatients.
  • 58
Prevention of relapse in generalized social phobia: results of a 24-week study in responders to 20 weeks of sertraline treatment.
  • 77
Sertraline treatment of generalized social phobia: a 20-week, double-blind, placebo-controlled study.
  • 200
Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder.
  • 248
...
1
2
3
4
5
...